MedPath

Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with Trismus After Radiotherapy

Phase 4
Recruiting
Conditions
Trismus
Head and Neck Cancer
Radiation Therapy Recipient
BOTOX
Interventions
Drug: Echo-guided Botox injection
Procedure: echo-guided normal saline injection
Registration Number
NCT06734598
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Trismus is a common side effect in head and neck cancer patients after radiation therapy. This project aims to explore the therapeutic effect of Botulinum toxin (Botox) injection to the masticatory muscles in the above-mentioned patients.

In this project, Botulinum toxin will be injected into the masticatory muscles (medial pterygoid and masticatory muscles), combined with oral rehabilitation exercises, to reduce the patient's masticatory muscle tension and spasm. Patient's mouth opening range, quality of life, trismus condition and pain will be evaluated to understand its efficacy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  1. Aged over 18 years old;
  2. Head and neck cancer patients must have completed radiotherapy for at least 3 months;
  3. Those whose mouth-opening distance is less than or equal to 3.5 cm (the functional cut-off point of trismus) and who have tightness or pain in the masticatory muscles;
  4. Medical condition is stable;
Exclusion Criteria
  1. Those who have undergone surgery on their masticatory muscles;
  2. Patients with obvious muscle atrophy or complete fibrosis of masticatory muscles ;
  3. Those with tumor recurrence at the time of admission;
  4. Those whose vital signs are unstable due to acute illness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Botox injectionEcho-guided Botox injection-
Normal Saline Injectionecho-guided normal saline injection-
Primary Outcome Measures
NameTimeMethod
Maximal Incisal OpeningFrom enrollment to the end of treatment at 6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei City, Taiwan

© Copyright 2025. All Rights Reserved by MedPath